Abstract. Curcumin is a biologically active ingredient abundantly present in the ground rhizomes of Curcuma longa with a wide range of bioactive properties, including antitumor effects. Hypoxia is a common characteristic of solid tumors, including osteosarcoma. However, whether curcumin has antitumor effects on osteosarcoma under hypoxic conditions, and its underlying molecular mechanisms, remain unclear. The present study demonstrated that the MG-63 osteosarcoma cell line exhibited increased proliferation and enhanced invasiveness upon exposure to hypoxic conditions. However, these effects were prevented by curcumin treatment. Further investigation revealed that curcumin may inhibit Notch1 upregulation induced by hypoxia. Overexpression of Notch1 via Notch1 cDNA transfection ameliorated curcumin-inhibited MG-63 cell growth under hypoxic conditions. Taken together, these data revealed that curcumin may suppress the growth of osteosarcoma cells in hypoxia via inhibiting Notch1 signaling.
Introduction
Osteosarcoma is the most common type of primary malignant bone cancer in children and adolescents, accounting for ~35% of all bone cancers (1) . One of the most prominent characteristics of osteosarcoma is local invasiveness and distant metastatic ability, which influences the therapy options and prognosis of the disease. With the use of neoadjuvant chemotherapy, the 5-year survival rate for non-metastasized cases has improved from 60 to 70%. However, the 5-year survival rate of patients with metastasis remains <30% (2) . Thus, novel therapeutic targets and strategies are required to improve the outcome in patients with osteosarcoma.
Hypoxia, caused by a limited blood supply from aberrant neovascularization and a rapidly growing tumor mass, is a common characteristic of solid tumors (3) . Hypoxic conditions are hypothesized to facilitate tumor progression by activating signaling pathways involved in cell proliferation, angiogenesis, apoptosis, invasion and metastasis (4) . The transcription factor hypoxia-inducible factor-1α (HIF-1α) is a key element in the cellular response to hypoxia and is widely expressed in a variety of solid tumors, including osteosarcoma (5) . Previous studies have demonstrated that HIF-1α expression levels are significantly associated with vascular endothelial growth factor and cyclooxygenase-2 expression levels in osteosarcoma tissues (6) . Furthermore, overexpression of HIF-1α is predictive of poor prognosis in osteosarcoma patients (7) . Thus, HIF-1α-targeted therapy may offer a novel strategy for the treatment of osteosarcoma.
The Notch signaling pathway is an evolutionarily conserved signaling pathway. The aberrant expression and activation of Notch signaling has been demonstrated in various types of malignancies and has been associated with cell proliferation, survival, apoptosis and differentiation (8) . To date, four Notch receptors have been identified in mammals, Notch1-4. The binding of a ligand (jagged 1, jagged 2, delta-like 1 or delta-like 4) to cell-surface Notch1-4 results in the cleavage and nuclear translocation of the Notch intracellular domain (NICD), leading to the expression of downstream targeting genes (9) . A previous study indicated that Notch1 is a downstream signaling component of HIF-1α under hypoxic conditions (10) . However, whether Notch1 inhibition may reverse the effects induced by hypoxia remains to be clarified.
Curcumin is a biologically active ingredient abundantly present in the ground rhizomes of Curcuma longa, which is widely distributed in Southeast Asia (11) . The wide range of bioactive properties of curcumin have been known for a number of years, and include anti-oxidative (12), anti-inflammatory (13), anticoagulative (14) and anti-atherosclerotic (15) properties. The antitumor effect of curcumin is of increasing interest (16) (17) (18) (19) . It has been reported that curcumin may exert antitumor effects in normoxic and hypoxic conditions (4) . As hypoxia is a key characteristic of the tumor microenvironment in osteosarcoma, the identification of molecules that contribute to the antitumor effects of curcumin may provide potential therapeutic targets. The present study investigated the effects of curcumin on the biological behaviors of osteosarcoma cells in a hypoxic microenvironment and the potential underlying molecular mechanisms.
Materials and methods
Cell culture and reagents. The MG-63 human osteosarcoma cell line was purchased from the American Type Culture Collection (Manassas, VA, USA) and was authenticated as to genotype and phenotype by the supplier. Cells were cultured in α-minimum essential medium (MEM) (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS; HyClone; GE Healthcare Life Sciences, Logan, UT, USA), 100 U/ml ampicillin (HyClone; GE Healthcare Life Sciences) and 100 µg/ml streptomycin (HyClone; GE Healthcare Life Sciences) at 37˚C in a humidified atmosphere of 5% CO 2 (normoxic conditions). To establish hypoxic conditions, cells were incubated in a humidified atmosphere consisting of 3% O 2 . Curcumin (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) was dissolved in dimethyl sulfoxide (DMSO; Sigma-Aldrich; Merck Millipore). The cells in the control group were treated with DMSO only. 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) was purchased from Sigma-Aldrich; Merck Millipore.
Cell viability assay. MG-63 cells were seeded into 96-well plates at a density of 5x10 3 cells per well and treated with various concentrations (0, 5 or 10 µM) of curcumin. The cells were cultured under normoxic or hypoxic conditions. At the indicated time points (12, 24, 36 or 48 h), cell viability was assessed by the MTT assay according to the manufacturer's protocol, and the absorbance was measured at a wavelength of 490 nm using a multiwell microplate reader (Bio-Tek Instruments, Inc., Winooski, VT, USA).
Matrigel invasion assays.
Transwell assays were performed using 8-µm Transwell chambers (EMD Millipore, Billerica, MA, USA) according to a protocol described previously (4) . Briefly, the membrane in the upper chamber was coated with Matrigel (25 µg per filter) 12 h prior to use. MG-63 cells were pretreated with curcumin for 24 h and suspended in α-MEM containing 0.1% FBS. Cells (5x10 4 ) were added to the upper chamber of the Transwell plates, and the lower compartments were filled with α-MEM containing 10% FBS. Assays were performed at 37˚C in normoxic or hypoxic (3% O 2 ) conditions. Following incubation for 48 h, the non-invasive cells were removed from the upper surface of the membrane using a cotton-tipped swab. Invading cells on the bottom surface of the filter were fixed with methanol and stained with 0.1% crystal violet. The invading cells were counted in ten representative fields (magnification, x200) under a light microscope (Nikon Corporation, Tokyo, Japan).
Notch1 cDNA transfection. The Notch1 expression plasmid was constructed by cloning the NICD-1 fragment into a pcDNA3.1 vector using the following primers: Forward, 5'-CACCATGGTGCTGCTGTCCCGCAAGCGCC-3' and reverse, 5'-TGCTTTAAATGCCACAGGAATGTGGG-3'. For overexpression of Notch1, MG-63 cells (0.5x10 6 /well) were seeded into a 6-well plate for 24 h and subsequently transfected with empty vector or Notch1 expression plasmid (5 µg cDNA) using Lipofectamine ® reagent (Invitrogen; Thermo Fisher Scientific, Inc.). Cells were incubated at 37˚C for 24 h and the culture medium was replaced with fresh medium. After a further incubation for 48 h, cell extracts were prepared and the expression levels of Notch1 were examined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting.
RT-qPCR. Total RNA was prepared from cells using TRIzol ® reagent (Invitrogen; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. cDNA was subsequently synthesized from 5 µg RNA using the Takara Reverse Transcription Reagent (Takara Bio, Inc., Otsu, Japan). Relative expression levels of the Notch1 gene transcript were determined by qPCR using the SYBR ® -Green Master mix (Takara Biotechnology Co., Ltd., Dalian, China) in the iQ5 Multicolor Real-Time PCR Detection system (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The primer sequences were as follows: Forward, 5'-GAGGCGTGGCAGACTATGC-3' and reverse, 5'-CTTGTACTCCGTCAGCGTGA-3' for Notch1; forward, 5'-CATCACTATCGGCAATGAGC-3' and reverse, 5'-GAC AGCACTGTGTTGGCATA-3' for β-actin. The following amplification conditions were used: Predenaturation at 94˚C for 4 min, followed by 40 cycles of denaturation at 94˚C for 30 sec, annealing at 60˚C for 30 sec and extension at 72˚C for 30 sec. The relative expression levels of Notch1 mRNA transcripts to GAPDH were determined using the 2 -ΔΔCq method as previously described (20) .
Western blot analysis. Total proteins were prepared from cells using radioimmunoprecipitation assay lysis buffer (Beyotime Institute of Biotechnology, Guangzhou, China) and protein concentration was determined using the Bicinchoninic Acid Protein assay kit (Pierce; Thermo Fisher Scientific, Inc.) according to the manufacturer's protocol. Equal quantities (25 µg) of protein were subjected to 10% SDS-PAGE and transferred to 0.22 µm polyvinylidene difluoride membranes. The membranes were blocked using 5% non-fat milk powder at room temperature for 1 h and incubated with primary anti-Notch1 (1:800; rabbit; cat. no. 3439; Cell Signaling Technology, Inc., Danvers, MA, USA) or anti-β-actin (1:1,000; rabbit; cat. no. 4970; Cell Signaling Technology, Inc.) or anti-HIF-1α (1:500; rabbit; cat. no. BS3514; Bioworld Technology, Inc., St. Louis Park, MN, USA) antibodies overnight at 4˚C. Following washing, the membranes were incubated with goat anti-rabbit horseradish peroxidase (HRP)-conjugated secondary antibodies (1:5,000; cat. no. ab97051; Abcam, Cambridge, MA, USA) at room temperature for 2 h. The bands were visualized using an Enhanced Chemiluminescence Detection system (GE Healthcare Life Sciences, Chalfont, UK). Quantity One Statistical analysis. Experiments were repeated three times with each sample analyzed in triplicate. The results are expressed as the mean ± standard deviation. Differences between groups were evaluated using a one-way analysis of variance followed by Dunnett's post hoc test. Statistical analysis was performed in SPSS software version 15.0 (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.
Results
Curcumin inhibits hypoxia-induced proliferation of osteosarcoma cells. Firstly, the effects of curcumin on the viability of cancer cells under hypoxic conditions were examined. MG-63 osteosarcoma cells were treated with 5 or 10 µM curcumin under normoxic or hypoxic conditions, for 12, 24, 36 or 48 h, and cell viability was assessed using an MTT assay. As presented in Fig. 1 , cell growth was accelerated in hypoxic conditions compared with control normoxic conditions (P=0.032). Curcumin treatment (5 µM) inhibited cell growth in normoxic conditions (P=0.028). Furthermore, hypoxia-induced cell proliferation was prevented by curcumin treatment at 5 and 10 µM concentrations (P=0.016). These results indicated that curcumin may inhibit the growth of osteosarcoma cells in normoxic and hypoxic conditions.
Curcumin inhibits hypoxia-induced invasion of osteosarcoma cells.
Cancer cells exposed to hypoxic conditions demonstrate enhanced invasiveness and metastasis (21, 22) . To investigate the effect of curcumin on the invasiveness of the MG-63 osteosarcoma cell line, a Transwell assay was performed. As presented in Fig. 2 , the number of invaded cells cultured in hypoxic conditions was significantly greater compared with control normoxic conditions (P=0.005). However, hypoxia-mediated cell invasiveness was markedly inhibited by curcumin treatment, which significantly reduced the number of invaded cells in a dose-dependent manner. These findings suggested that curcumin may inhibit the invasiveness of cancer cells under hypoxic conditions.
Curcumin inhibits hypoxia-induced Notch1 upregulation. Previous studies indicated that Notch1 is required for the hypoxia-induced proliferation and invasion of cancer cells (23).
The present study investigated whether curcumin has an effect on hypoxia-induced Notch1 upregulation in MG-63 cells. As presented in Fig. 3A , RT-qPCR revealed that the relative mRNA expression levels of Notch1 in cells cultured in hypoxic conditions were markedly greater compared with those from normoxic conditions (P=0.007). However, the hypoxia-induced Notch1 mRNA expression levels were markedly reduced by 5 (P=0.007) and 10 µM (P=0.003) curcumin. These observations were further supported at the protein level by western blotting (Fig. 3B) . Treatment with curcumin markedly diminished the hypoxia-induced upregulation of the HIF-1α and Notch1 proteins. Together, these data indicated that curcumin may inhibit hypoxia-induced Notch1 upregulation in a dose-dependent manner.
Overexpression of Notch1 reduces curcumin-induced cell growth inhibition under hypoxia.
To determine the underlying mechanisms of Notch1 in curcumin-inhibited cell growth under hypoxic conditions, MG-63 cells were transfected with the Notch1 cDNA. The mRNA and protein expression levels of Notch1 in MG-63 cells were detected by RT-qPCR and western blotting, respectively. As presented in Fig. 4A , RT-qPCR revealed that Notch1 mRNA expression levels were approximately 3-fold greater in Notch1 cDNA-transfected cells compared with cells transfected with an empty vector (P=0.0007). These results were supported by western blotting data (Fig. 4B) . The effects of Notch1 overexpression on curcumin-mediated cell growth inhibition were subsequently assessed under hypoxia in MG-63 cells. Notch1 cDNA-transfected and empty vector-transfected control cells were cultured in the absence or presence of 10 µM curcumin under normoxia, for 12, 24, 36 or 48 h, and cell viability was assessed by an MTT assay. As presented in Fig. 4C , the promoted cell growth in hypoxia was prevented by curcumin treatment at a concentration of 10 µM (P=0.001). Cells transfected with Notch1 cDNA demonstrated increased cell growth compared with empty vector-transfected control cells under normoxia (P=0.007). Notably, curcumin-inhibited cell growth in hypoxia was reversed by Notch1 overexpression (P=0.019). The Notch1 protein expression levels in each group were detected by western blotting (Fig. 4D) . Collectively, these data indicated that Notch1 may be involved in curcumin-inhibited cell growth in hypoxia.
Discussion
Although osteosarcoma is a relatively rare type of malignant cancer, the high incidence in children and adolescents make it a major public health issue worldwide. In the past decade, despite progress in the understanding of osteosarcoma and the advent of multi-agent chemotherapy, there has been no significant improvement in prognosis for patients with osteosarcoma. Developments in molecular biology have provided insight into the molecular pathogenesis of osteosarcoma (24, 25) . Previous studies (5, 26) have demonstrated that hypoxia is a common phenomenon within solid tumors, including osteosarcoma. Hypoxia-mediated upregulation of HIF-1α may act on multiple downstream genes associated with tumor progression (27) . HIF-1α overexpression is a frequent event in osteosarcoma and has been identified as an independent prognostic biomarker in osteosarcoma (28) , indicating that hypoxia is a feature of osteosarcoma. Therefore, it may be more relevant to examine the response of osteosarcoma to chemotherapeutics under hypoxic conditions. Evidence from experimental and clinical studies have indicated a critical role for hypoxia in the malignant progression of solid tumors (27) . Hypoxia has become a central issue in tumor physiology and cancer treatment due to its multiple roles in cancer cell genomic instability (29) , angiogenesis (30), invasiveness (31) , metastasis (32), resistance to cell death (33) , metabolism reprogramming (34), chemoresistance (35) and radioresistance (36) . A hypoxic microenvironment has been confirmed by histological studies of osteosarcoma specimens (37) . It was reported that elevated HIF-1α protein expression levels were associated with shortened disease-free survival and treatment resistance in osteosarcoma patients (6) . In addition, a recent study demonstrated that osteosarcoma The protein expression levels of HIF-1α and Notch1 were detected by western blotting using β-actin as an internal loading control. HIF-1α, hypoxia inducible factor 1α. cells exhibited enhanced proliferation and invasiveness when exposed to hypoxic conditions (38) . Consistent with this, the present study observed that the proliferation and invasiveness of MG-63 cells were markedly promoted by hypoxic conditions. A previous study indicated that curcumin is a potent anticancer agent, which acts by targeting multiple cell signaling pathways involved in cancer progression (16) . To date, various anti-cancer effects of curcumin have been revealed, including its ability to suppress proliferation, induce apoptosis and inhibit the invasion and metastasis of cancer cells (39) . However, previous studies were primarily focused on the anticancer effects of curcumin under normoxic conditions, rather than focusing on its anticancer effects under hypoxic conditions. Duan et al (40) reported that curcumin may inhibit hypoxia-induced proliferation and epithelial-mesenchymal transition of hepatic carcinoma cells. This study used the chemical CoCl 2 to establish hypoxic conditions, which is a poor reflection of real hypoxic conditions, although CoCl 2 may induce HIF-1α accumulation in cancer cells. In the present study, a culture condition containing 3% O 2 was used to examine the effects of curcumin on osteosarcoma cell proliferation and invasion. These results demonstrated that curcumin may inhibit hypoxia-induced proliferation and invasion of osteosarcoma cells. This suggested that curcumin may serve pivotal roles in tumor suppression under normoxic and hypoxic conditions. Notch signaling is a highly conserved cell signaling system involved in normal organ development. Recent studies (41, 42) have suggested that the Notch1 signaling pathway serves a critical role in osteosarcoma pathogenesis, development, invasion and metastasis, which indicates that Notch1 is a potential therapeutic target in osteosarcoma. In the present study, in addition to enhanced proliferation and invasiveness, the Notch1 expression levels in MG-63 cells were markedly increased by hypoxia treatment. Furthermore, curcumin, which has been revealed to inhibit hypoxia-induced HIF-1α expression, may suppress the expression levels of Notch1. These results indicated that Notch1 may be a downstream gene of HIF-1α in osteosarcoma cells and suggested that curcumin may serve as a potential anticancer agent for the treatment of osteosarcoma.
In conclusion, the current study demonstrated that the MG-63 osteosarcoma cell line exhibited increased rates of proliferation and enhanced invasiveness upon exposure to hypoxic conditions. However, the effects induced by hypoxia in MG-63 cells were prevented by curcumin treatment. Further investigation revealed that curcumin may inhibit the Notch1 upregulation induced by hypoxia. Overexpression of Notch1 by Notch1 cDNA transfection ameliorated curcumin-inhibited MG-63 cell growth under hypoxic conditions. Taken together, the results of the present study revealed that curcumin may suppress the growth of osteosarcoma cells in hypoxia via inhibition of Notch1 signaling. The protein expression levels of Notch1 in each group were assessed by western blotting; β-actin served as an internal loading control. Data are expressed as the mean ± standard deviation (n=3). IOD, integrated optical density.
